---
layout: default
title: Cisatracurium
description: "Cisatracurium çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚åˆæ­¥è­‰æ“šç­‰ç´š L4ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 47
evidence_level: L4
indication_count: 10
---

# Cisatracurium

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L4</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Cisatracuriumï¼šå¾ç¥ç¶“è‚Œè‚‰é˜»æ–·åˆ°å­ç™²å‰ç—‡

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Cisatracurium å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Cisatracurium æ˜¯ä¸€ç¨®é«˜é¸æ“‡æ€§çš„éå»æ¥µåŒ–ç¥ç¶“è‚Œè‚‰é˜»æ–·åŠ‘ï¼ŒåŸæœ¬ç”¨æ–¼æ‰‹è¡“è¼”åŠ©å’ŒåŠ è­·ç—…æˆ¿çš„è‚Œè‚‰é¬†å¼›ã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**å­ç™²å‰ç—‡ (Preeclampsia)** æœ‰æ•ˆï¼Œ
ç›®å‰æœ‰ **2 å€‹è‡¨åºŠè©¦é©—**å’Œ **2 ç¯‡æ–‡ç»**æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>


## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | ä½œç‚ºæ‰‹è¡“å…¨èº«éº»é†‰åŠ‘ä¹‹è¼”åŠ©åŠ‘æˆ–åŠ è­·ç—…æˆ¿ä½¿ç”¨ï¼Œç”¨ä»¥é¬†å¼›éª¨éª¼è‚Œï¼Œå¹«åŠ©æ°£ç®¡æ’ç®¡åŠèˆ‡äººå·¥å‘¼å¸å™¨çš„å”èª¿ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | cauda equina syndromeã€å­ç™²å‰ç—‡ã€obsolete neurogenic bladder (disease)ã€migraine disorderã€thrombotic diseaseã€irritable bowel syndromeã€migraine with brainstem auraã€mild pre-eclampsiaã€severe pre-eclampsiaã€neurocirculatory asthenia |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.99% |
| è­‰æ“šç­‰ç´š | L4 |
| å°ç£ä¸Šå¸‚ | âœ“ å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | 6 å¼µ |
| å»ºè­°æ±ºç­– | Research Question |


## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. cauda equina syndrome</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

### ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ

<p class="key-answer" data-question="é€™å€‹è—¥ç‰©çš„ä½œç”¨æ©Ÿè½‰æ˜¯ä»€éº¼ï¼Ÿ">
ç›®å‰ç¼ºä¹è©³ç´°çš„ä½œç”¨æ©Ÿè½‰è³‡æ–™ã€‚æ ¹æ“šå·²çŸ¥è³‡è¨Šï¼ŒCisatracurium æ˜¯ä¸€ç¨®éå»æ¥µåŒ–ç¥ç¶“è‚Œè‚‰é˜»æ–·åŠ‘ï¼Œ
å…¶åœ¨æ‰‹è¡“ä¸­çš„è‚Œè‚‰é¬†å¼›æ•ˆæœå·²è¢«è­‰å¯¦ã€‚é›–ç„¶å…¶åœ¨å­ç™²å‰ç—‡ç®¡ç†ä¸­çš„è§’è‰²å°šæœªç¢ºç«‹ï¼Œ
ä½†åœ¨å‰–è…¹ç”¢æ‰‹è¡“ä¸­å¯èƒ½æœ‰åŠ©æ–¼è‚Œè‚‰é¬†å¼›ï¼Œé€™å¯èƒ½é–“æ¥æ”¯æŒå…¶åœ¨å­ç™²å‰ç—‡ä¸­çš„æ‡‰ç”¨ã€‚
</p>

<div class="key-takeaway">
æ­¤é æ¸¬åŸºæ–¼è—¥ç‰©çš„ä½œç”¨æ©Ÿè½‰ï¼Œèˆ‡ç¾æœ‰è‡¨åºŠè­‰æ“šæ–¹å‘ä¸€è‡´ã€‚
</div>

### è‡¨åºŠè©¦é©—

| è©¦é©—ç·¨è™Ÿ | éšæ®µ | ç‹€æ…‹ | äººæ•¸ | ä¸»è¦ç™¼ç¾ |
|---------|------|------|------|---------|
| [NCT04645719](https://clinicaltrials.gov/study/NCT04645719) | Phase 3 | æœªçŸ¥ | 75 | Magnesium sulfate åœ¨è‚¥èƒ–æ‚£è€…ä¸­çš„æœ€ä½³åŠ‘é‡ç ”ç©¶ï¼Œæ¶‰åŠå­ç™²å‰ç—‡æ§åˆ¶ã€‚ |
| [NCT04003688](https://clinicaltrials.gov/study/NCT04003688) | NA | å®Œæˆ | 74 | æ¯”è¼ƒå…©ç¨®æ–¹æ³•è¨ˆç®—è‚¥èƒ–æ‚£è€…çš„ç¡«é…¸é‚åŠ‘é‡ï¼Œæ¶‰åŠå­ç™²å‰ç—‡ã€‚ |

### ç›¸é—œæ–‡ç»

| PMID | å¹´ä»½ | é¡å‹ | æœŸåˆŠ | ä¸»è¦ç™¼ç¾ |
|------|-----|------|------|---------|
| [41103680](https://pubmed.ncbi.nlm.nih.gov/41103680/) | 2025 | Case series | Anesthesiology and pain medicine | ç‚ç—‡ç´°èƒå› å­å°è…¹éƒ¨æ‰‹è¡“å¾Œåæ‡‰çš„è² é¢å½±éŸ¿ã€‚ |
| [18383970](https://pubmed.ncbi.nlm.nih.gov/18383970/) | 2008 | Case series | Revista espanola de anestesiologia y reanimacion | è©•ä¼° remifentanil åœ¨é«˜é¢¨éšªå‰–è…¹ç”¢ä¸­çš„è¡€æµå‹•åŠ›å­¸æ§åˆ¶ã€‚ |

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. preeclampsia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.99%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. obsolete neurogenic bladder (disease)</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.99%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. migraine disorder</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.98%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. thrombotic disease</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.97%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.97%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. irritable bowel syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.97%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.97%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. migraine with brainstem aura</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.97%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.97%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. mild pre-eclampsia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.96%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.96%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. severe pre-eclampsia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.95%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.95%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. neurocirculatory asthenia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.95%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.95%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›éƒ¨è—¥è£½å­—ç¬¬060359è™Ÿ | è¡›å¹³é©æ³¨å°„æ¶²2æ¯«å…‹/æ¯«å‡ | æ³¨å°„æ¶²åŠ‘ | æœ¬å“ç‚ºä¸€é«˜é¸æ“‡æ€§åŠç«¶çˆ­æ€§çš„éå»æ¥µåŒ–ç¥ç¶“è‚Œè‚‰é˜»æ–·åŠ‘... |
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬026541è™Ÿ | "å¡æ¯”"è‚Œé¬†å¼›æ³¨å°„æ¶²2æ¯«å…‹/æ¯«å‡ | æ³¨å°„åŠ‘ | æœ¬å“ç‚ºä¸€é«˜é¸æ“‡æ€§åŠç«¶çˆ­æ€§çš„éå»æ¥µåŒ–ç¥ç¶“è‚Œè‚‰é˜»æ–·åŠ‘... |
| è¡›ç½²è—¥è¼¸å­—ç¬¬022759è™Ÿ | è‚Œå¼›é©ã€€é«˜å–®ä½æ³¨å°„æ¶²ï¼•å…¬çµ²/å…¬æ’® | æ³¨å°„åŠ‘ | æœ¬å“ç‚ºä¸€é«˜é¸æ“‡æ€§åŠç«¶çˆ­æ€§çš„éå»æ¥µåŒ–ç¥ç¶“è‚Œè‚‰é˜»æ–·åŠ‘... |

## å®‰å…¨æ€§è€ƒé‡

- **è—¥ç‰©äº¤äº’ä½œç”¨**ï¼š
  - ä¸»è¦äº¤äº’ä½œç”¨è—¥ç‰©ï¼šKanamycinï¼ˆMajorï¼‰ã€Neomycinï¼ˆMajorï¼‰ã€Paromomycinï¼ˆMajorï¼‰ã€Polymyxin Bï¼ˆMajorï¼‰ã€Streptomycinï¼ˆMajorï¼‰


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**Premature Birth** ğŸŸ¢ Minor
- Parenteral medications formulated in multidose vials often contain benzyl alcohol as a preservative.  Their use is considered by drug manufacturers to be contraindicated in neonates, particularly premature infants and infants of low birth weight.  Wh...

**Burns** ğŸŸ¢ Minor
- Patients with burns may develop resistance to non-depolarizing neuromuscular blocking agents.  These patients may experience a shorter duration of action and/or require higher dosages of the drugs.  The extent of altered response depends on the durat...

**é‡ç—‡è‚Œç„¡åŠ› (Myasthenia Gravis)** ğŸŸ¢ Minor
- The use of neuromuscular blocking agents may cause prolonged respiratory paralysis.  Therapy with neuromuscular blocking agents should be administered cautiously in patients with myasthenia gravis.  Use of a peripheral nerve stimulator may be helpful...

**Paresis** ğŸŸ¢ Minor
- Patients with hemiparesis or paraparesis may require higher dosages of non-depolarizing neuromuscular blocking agents in the affected limbs.  Neuromuscular monitoring should be performed on a non-paretic limb to avoid inaccurate dosing.

**Respiratory Insufficiency** ğŸŸ¢ Minor
- Neuromuscular blocking agents can cause respiratory depression and paralysis.  Therapy with neuromuscular blocking agents should be administered cautiously in patients with pulmonary impairment.  Treatment of respiratory paralysis consists of positiv...

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šResearch Question**

**ç†ç”±ï¼š**
ç›®å‰çš„è­‰æ“šä¸»è¦ä¾†è‡ªæ–¼ç¡«é…¸é‚ç›¸é—œçš„ç ”ç©¶ï¼Œèˆ‡ Cisatracurium çš„ç›´æ¥é—œè¯æ€§æœ‰é™ã€‚
éœ€è¦é€²ä¸€æ­¥ç ”ç©¶å…¶åœ¨å­ç™²å‰ç—‡ä¸­çš„å…·é«”ä½œç”¨ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- è©³ç´°çš„è—¥ç‰©ä½œç”¨æ©Ÿè½‰è³‡æ–™ï¼ˆMOAï¼‰
- æ›´ç›´æ¥çš„è‡¨åºŠè©¦é©—æ•¸æ“š
- è©•ä¼°åœ¨å­ç™²å‰ç—‡ç®¡ç†ä¸­çš„å®‰å…¨æ€§å’Œæœ‰æ•ˆæ€§


---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Vismodegib]({{ "/drugs/vismodegib/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Salicylamide]({{ "/drugs/salicylamide/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Minoxidil]({{ "/drugs/minoxidil/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Dl-Alpha-Tocopherol]({{ "/drugs/dl-alpha-tocopherol/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Probenecid]({{ "/drugs/probenecid/" | relative_url }}) - è­‰æ“šç­‰ç´š L4

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Cisatracuriumè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/cisatracurium/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_cisatracurium,
  title = {Cisatracuriumè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/cisatracurium/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
